InvestorsHub Logo
Followers 144
Posts 10941
Boards Moderated 0
Alias Born 04/02/2006

Re: H2R post# 3116

Thursday, 11/09/2017 5:17:56 PM

Thursday, November 09, 2017 5:17:56 PM

Post# of 3329
H2R did you buy DVAX? Their Heplisav-B vaccine got approved today.. Up over $2 AH.. Stock will be in the mid $30 next year..

EXEL, DVAX, ARTH are my biotech winners this year and of course my losers are AGEN and KERX.. I am regretting about AGEN the most.. arrrgh

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.